)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Cosciens Biopharma (CSCI) investor relations material
Cosciens Biopharma Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary14 Aug, 2025
Executive summary
Revenue grew 17% year-over-year in Q2 2025, with gross profit up 19% and operating expenses down 28% compared to Q2 2024.
Strategic initiatives included a reconstituted Board, new CEO, and a 27% workforce reduction to streamline operations.
Announced voluntary delisting from Nasdaq to focus on TSX listing and reduce costs, with delisting expected to be effective September 5, 2025.
Progress made on business optimization, cost realignment, and portfolio growth evaluation.
Financial highlights
Q2 2025 revenue was $2.7 million, up from $2.3 million in Q2 2024, mainly due to increased sales and merger-related Macrilen revenue.
Q2 2025 net loss was $2.4 million ($0.75/share) versus $1.4 million ($0.64/share) in Q2 2024, with the increase mainly due to merger timing.
Six-month 2025 revenue was $4.2 million, down from $4.4 million in 2024, reflecting lower sales of core products offset by Macrilen revenue.
Six-month net loss was $6.0 million ($1.90/share) compared to $2.8 million ($1.39/share) in 2024, mainly due to merger effects and changes in warrant/DSU liabilities.
Cash and cash equivalents stood at $9.3 million as of June 30, 2025.
Outlook and guidance
Full run-rate savings from restructuring and zero-based budgeting expected to materialize in early 2026.
Plans to file Form 15-F to terminate U.S. SEC reporting obligations after Nasdaq delisting.
Ongoing focus on cost control, operational discipline, and product portfolio optimization for long-term growth.
Assess timeline to cease US public reporting.
Elaborate on new category expansion for ingredients.
What's the plan for commercializing beta glucan bars?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cosciens Biopharma earnings date
Q3 202511 Nov, 2025
Next Cosciens Biopharma earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Cosciens Biopharma Inc is a Chinese biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. The company targets therapeutic areas including oncology, immunology, and central nervous system disorders. It employs proprietary drug discovery platforms and engages in clinical development activities. The company is headquartered in Suzhou, China, and its shares are listed on the SSE STAR Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage